Effect of small dose esketamine on perioperative neurocognitive disorder and postoperative depressive symptoms in elderly patients undergoing major elective noncardiac surgery for malignant tumors: A randomized clinical trial

Cuifang Huang,Ruimin Yang,Xianlong Xie,Huijun Dai,Linghui Pan
DOI: https://doi.org/10.1097/md.0000000000040028
IF: 1.6
2024-10-30
Medicine
Abstract:To date, cancer is the second leading cause of death worldwide after cardiovascular diseases, surgical resection remains one of mainstay treatments for most cancers. Perioperative neurocognitive disorder (PND) is a severe complication following surgery and anesthesia in elderly patients. It is usually manifested by disturbances of the cognitive ability, orientation ability, thinking, emotion and sleep, and often accompanied by dysfunction of personality, social ability and communication skills, and other social activities of the ability. PND includes cognitive decline diagnosed before the operation; postoperative delirium (POD), delayed neurocognitive recovery (up to 30 days after the procedure) and postoperative neurocognitive disorder (up to 12 months, POCD). [ 1 ] Due to the increase in the aging population, half of the elderly globally have received a surgical procedure. A quarter of those who undergo major surgery will experience noticeable cognitive decline, and half of all patients will suffer from permanent cognitive impairment. [ 2 ] PND results in more extended hospitalization, increased disability, social burden, and mortality. However, effective pharmacotherapies to prevent or reduce PND are not currently available.
medicine, general & internal
What problem does this paper attempt to address?